Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.
The consumption of whole-fat dairy products may reduce cardiovascular disease and mortality risk, contrary to current dietary guidelines that advise limited consumption of fat-free or low-fat dairy products.
A guideline-based approach directing pharmacological treatment to adults more likely to have CVD events may maximize absolute risk reduction of treatment.
Excess risk differed by up to 5 times across different diagnosis age groups.
The substantial burden of cardiovascular disease in patients with diabetes has led to the exploration of various cardiovascular disease prevention strategies, including the use of aspirin.
Findings may have implications for future cholesterol treatment paradigms.
Black survivors of in-hospital cardiac arrest have lower survival at 1, 3, 5 years vs whites.
Proportion achieving target BP increased with use of triple combo pill vs usual care at 6 months.
Benefit seen for adoption of healthy lifestyle even after T2DM diagnosis made.
Physicians weigh in on the need to develop a screening strategy.
No Impact on Carotid Artery Intima-Media Thickness Following Cessation of Menopausal Hormone TherapyAugust 13, 2018
A follow-up study from KEEPS found that cessation of menopausal hormone therapy did not change the expected trajectory of carotid artery intima-media thickness over a 3-year period.
High total HDL cholesterol in postmenopausal women may mask heart disease risk.
An elderly woman with a history of hypertension and metastatic bladder cancer presents to the ED with bilateral finger pain and cyanosis associated with a 15-lb weight loss.
This represents the prospective study confirming an independent relationship between cardiovascular mortality and oxidative DNA damage in type 2 diabetes.
Adoption of the guidelines would label more than half of 45- to 75-year-olds as having hypertension.
Effectiveness of care and healthcare resource use for diabetes or cardiovascular disease were comparable among patients receiving care from an NP vs those managed by a PA.
Siblings of patients with rheumatoid arthritis appear to have an increased risk for acute coronary syndrome, which suggests there is a shared susceptibility between the 2 conditions.
Agency offers steps to minimize exposure, particularly for those with chronic conditions.
A literature review revealed that the use of care navigators in conjunction with follow-up telephone calls from nursing staff improved transition of care and readmission rates in patients with congestive heart failure.
An observational study was conducted in order to determine the accuracy and quality of readings provided by home blood pressure monitoring systems.
Lower incidence of major cardiovascular events with Mediterranean diet supplemented with oil, nuts.
Nonsteroidal anti-inflammatory drug use mediated a substantial amount of cardiovascular disease risk in osteoarthritis.
Researchers assessed the effect of testosterone, estradiol, dehydroepiandrosterone, and sex hormone-binding globulin levels on coronary heart disease, heart failure, and cardiovascular disease in postmenopausal women.
Perioperative red blood cell transfusion linked to increased adjusted odds of VTE, DVT, PE
Racial differences persist in statin use among adults, specifically African American adults, who are less likely to be treated with any statin or guideline-recommended statin intensity compared with white adults.
The United States Preventive Services Task Force does not recommend screening with resting or exercise electrocardiography in asymptomatic individuals at low risk for cardiovascular disease events.
Alcohol consumption may be inversely related to nonfatal CHD risk but positively correlated with risks for other stroke subtypes.
Age at diagnosis, sex, BMI, and thyroid-stimulating hormone suppression therapy affect CVD risk
Risk of cardiovascular outcomes was greatest for those with the most active atopic eczema.
Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths.